bullish
More Discussions on Impacts of Celltrion's KOSPI200 Inclusion
485 Views23 Aug 2017 04:03
Celltrion Inc (068270 KS) said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI.
Below is...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion (068270 KS): Korean Making Biological Drugs for the West05 Jan 2018
- Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions28 Sep 2017
- Celltrion Has Potential Manufacturing Headaches07 Sep 2017
- More Discussions on Impacts of Celltrion's KOSPI200 Inclusion23 Aug 2017
- NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move10 Aug 2017
- Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options17 Jul 2017
- Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics13 Jul 2017
x